DNA Barcoding, GC-MS Analysis, and Biological Activity Prediction of Bioactive Compounds in the Seeds of Celastrus paniculatus: A Source of Lead Compounds for Neurological Disorders
Background: Neurodegenerative disorders are multifactorial by nature and are difficult to treat. Limitations of existing drugs due to narrow therapeutic profiles have led to the consideration of alternative strategies, including natural products and their derivatives. Celastrus paniculatus is an endangered medicinal plant widely used in Ayurveda and is known for multiple therapeutic benefits, including effectiveness against cognitive impairment and possessing anti-epileptic, memory-enhancing, and anti-inflammatory properties. Aim: The present study aimed to identify the secondary metabolites present in the seeds of C. paniculatus and to estimate their pharmacological parameters to act as leads using computational predictive analysis. Methods: Seed extracts were prepared using methanol and ethanol and analysed using GC–MS to identify compounds. The identified compounds were evaluated using the Lipinski filter and computational predictive analysis of pharmacological parameters, including absorption, distribution, metabolism, excretion, toxicity, and blood–brain barrier crossing potential, along with biological activity prediction. Results: A total of 32 compounds were identified from the methanol extract, and 18 compounds from the ethanol extract. Among these, 47 compounds exhibited drug-likeness based on the Lipinski filter. Out of these, five compounds—phenethylamine, trans-tetrahydro-3,4-furandiol mononitrate, extroamphetamine, 13-alpha-benzoyloxylupanine, and 2-palmitoylglycerol—satisfied pharmacological parameters of absorption, distribution, metabolism, excretion, and toxicity and exhibited blood–brain barrier crossing potential. These compounds also showed a higher probability of activity as neuroprotective agents. Conclusion: GC-MS analysis of C. paniculatus seed extracts identified 49 phytochemicals, among which phenethylamine, trans-tetrahydro-3,4-furandiol mononitrate, dextroamphetamine, 13α-benzoyloxylupanine, and 2-palmitoylglycerol showed promising drug-